BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ortega MA, Fraile-Martínez O, García-Honduvilla N, Coca S, Álvarez-Mon M, Buján J, Teus MA. Update on uveal melanoma: Translational research from biology to clinical practice (Review). Int J Oncol 2020;57:1262-79. [PMID: 33173970 DOI: 10.3892/ijo.2020.5140] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu B, Yao X, Zhang C, Liu Y, Wei L, Huang Q, Wang M, Zhang Y, Hu D, Wu W. PTK6 inhibits autophagy to promote uveal melanoma tumorigenesis by binding to SOCS3 and regulating mTOR phosphorylation. Cell Death Dis 2023;14:55. [PMID: 36690663 DOI: 10.1038/s41419-023-05590-w] [Reference Citation Analysis]
2 Liu B, Yao X, Zhang C, Li W, Wang Y, Liao Q, Li Z, Huang Q, Zhang Y, Wu W. LINC01278 Induces Autophagy to Inhibit Tumour Progression by Suppressing the mTOR Signalling Pathway. Oxid Med Cell Longev 2023;2023:8994901. [PMID: 36713034 DOI: 10.1155/2023/8994901] [Reference Citation Analysis]
3 Han LM, Lee KW, Uludag G, Seider MI, Afshar AR, Bloomer MM, Pekmezci M. Prognostic Value of BAP1 and Preferentially Expressed Antigen in Melanoma (PRAME) Immunohistochemistry in Uveal Melanomas. Modern Pathology 2023. [DOI: 10.1016/j.modpat.2022.100081] [Reference Citation Analysis]
4 Amaro A, Pfeffer M, Pfeffer U, Reggiani F. Evaluation and Comparison of Multi-Omics Data Integration Methods for Subtyping of Cutaneous Melanoma. Biomedicines 2022;10. [PMID: 36551996 DOI: 10.3390/biomedicines10123240] [Reference Citation Analysis]
5 Cheng Y, Liu J, Fan H, Liu K, Zou H, You Z. Integrative analyses of a mitophagy-related gene signature for predicting prognosis in patients with uveal melanoma. Front Genet 2022;13:1050341. [PMID: 36544483 DOI: 10.3389/fgene.2022.1050341] [Reference Citation Analysis]
6 Hu Y, Cai J, Ye M, Mou Q, Zhao B, Sun Q, Lou X, Zhang H, Zhao Y. Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1037128] [Reference Citation Analysis]
7 Chen W, Yan L, Long B, Lin L, Pan J. Identification of Immune-Related lncRNAs for Predicting Prognosis and Immune Landscape Characteristics of Uveal Melanoma. Journal of Oncology 2022;2022:1-12. [DOI: 10.1155/2022/7680657] [Reference Citation Analysis]
8 Luz Pessuti C, Fialho Costa D, Ribeiro KS, Abdouh M, Tsering T, Nascimento H, Commodaro AG, Affonso Antunes Marcos A, Torrecilhas AC, Belfort RN, Belfort Jr R, Valdemarin Burnier J. Characterization of Extracellular vesicles isolated from different Liquid biopsies of uveal melanoma patients. J Circ Biomark 2022;11:36-47. [DOI: 10.33393/jcb.2022.2370] [Reference Citation Analysis]
9 Jayaraj DP, Sen S, Kaur K, Gupta K, Taluja S. A Bioinformatics Approach To Reveal Common Genes And Molecular Pathways Shared By Cutaneous Melanoma and Uveal Melanoma.. [DOI: 10.1101/2022.05.30.493940] [Reference Citation Analysis]
10 Grigoryan EN. Pigment Epithelia of the Eye: Cell-Type Conversion in Regeneration and Disease. Life 2022;12:382. [DOI: 10.3390/life12030382] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Xie J, Chen L, Tang Q, Wei W, Cao Y, Wu C, Hang J, Zhang K, Shi J, Wang M. A Necroptosis-Related Prognostic Model of Uveal Melanoma Was Constructed by Single-Cell Sequencing Analysis and Weighted Co-Expression Network Analysis Based on Public Databases. Front Immunol 2022;13:847624. [PMID: 35242144 DOI: 10.3389/fimmu.2022.847624] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
12 Zhao S, Jiang H, Liu J, Li D, Li B, Long Q, Zheng L, Gu H, Wang F. Comprehensive Analysis of Enhancer RNAs Identifies LINC00689 and ELFN1-AS1 as Novel Prognostic Biomarkers in Uveal Melanoma. Disease Markers 2022;2022:1-11. [DOI: 10.1155/2022/5994800] [Reference Citation Analysis]
13 Peil J, Bock F, Kiefer F, Schmidt R, Heindl LM, Cursiefen C, Schlereth SL. New Therapeutic Approaches for Conjunctival Melanoma-What We Know So Far and Where Therapy Is Potentially Heading: Focus on Lymphatic Vessels and Dendritic Cells. Int J Mol Sci 2022;23:1478. [PMID: 35163401 DOI: 10.3390/ijms23031478] [Reference Citation Analysis]
14 Yang C, Wang R, Hardy P. Potential of miRNA-Based Nanotherapeutics for Uveal Melanoma. Cancers (Basel) 2021;13:5192. [PMID: 34680340 DOI: 10.3390/cancers13205192] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Du R, Zhao P, Wu S, Gao Y, Wu R, Yang M, Song W, Gao H. Sendeng-4 Suppressed Melanoma Growth by Induction of Autophagy and Apoptosis. Evid Based Complement Alternat Med 2021;2021:5519973. [PMID: 34475961 DOI: 10.1155/2021/5519973] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Spungen H, Weingrow D. Uveal Melanoma Identified as Ocular Mass on Point-of-care Ultrasound. Clin Pract Cases Emerg Med 2021;5:367-8. [PMID: 34437051 DOI: 10.5811/cpcem.2021.4.52115] [Reference Citation Analysis]
17 Xie L, Yue W, Ibrahim K, Shen J. A Long-Acting Curcumin Nanoparticle/In Situ Hydrogel Composite for the Treatment of Uveal Melanoma. Pharmaceutics 2021;13:1335. [PMID: 34575410 DOI: 10.3390/pharmaceutics13091335] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
18 Wróblewska JP, Lach MS, Kulcenty K, Galus Ł, Suchorska WM, Rösel D, Brábek J, Marszałek A. The Analysis of Inflammation-Related Proteins in a Cargo of Exosomes Derived from the Serum of Uveal Melanoma Patients Reveals Potential Biomarkers of Disease Progression. Cancers (Basel) 2021;13:3334. [PMID: 34283046 DOI: 10.3390/cancers13133334] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
19 Jiu X, Liu Y, Wen J. Artesunate combined with verteporfin inhibits uveal melanoma by regulation of the MALAT1/yes-associated protein signaling pathway. Oncol Lett 2021;22:597. [PMID: 34188699 DOI: 10.3892/ol.2021.12858] [Reference Citation Analysis]